Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Crazy About CIRCOR International, Inc. (CIR)

Is CIRCOR International, Inc. (NYSE:CIR) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research. Although there have been several high profile failed hedge fund picks, the consensus picks among hedge fund investors have historically outperformed the market after adjusting for known risk attributes. It’s not surprising given that hedge funds have access to better information and more resources to find the latest market-moving information.

CIRCOR International, Inc. (NYSE:CIR) shareholders have witnessed an increase in enthusiasm from smart money recently. It might come as a surprise, considering a drop of 26.43% in the stock value of CIRCOR International, Inc. (NYSE:CIR), during the last quarter. Such hedge fund behavior prompted us to find out more about hedgies that held positions in CIRCOR International, Inc. (NYSE:CIR), at the end of September.

One of the best ways to understand hedge fund sentiment towards a stock is to study the behavior of hedgies towards stocks with similar market caps. At the end of this article, we will also compare CIRCOR International, Inc. (NYSE:CIR) to other stocks, including Transocean Partners LLC (NYSE:RIGP), The Pep Boys – Manny, Moe & Jack (NYSE:PBY), and Independent Bank Group Inc (NASDAQ:IBTX) to get a better sense of its popularity.

Follow Circor International Inc (NYSE:CIR)
Trade (NYSE:CIR) Now!

In the financial world, there are several methods shareholders have at their disposal to appraise stocks. Some of the best methods are hedge fund and insider trading interest. Our researchers have shown that, historically, those who follow the best picks of the elite investment managers can outpace the broader indices by a healthy margin (see the details here).

Now, we’re going to go over the key action surrounding CIRCOR International, Inc. (NYSE:CIR).

How have hedgies been trading CIRCOR International, Inc. (NYSE:CIR)?

At the end of the third quarter, a total of 11 of the hedge funds tracked by Insider Monkey held long positions in this stock, an increase of 22% from the second quarter. With the smart money’s positions undergoing their usual ebb and flow, there exists a few key hedge fund managers who were boosting their holdings considerably (or already accumulated large positions).

According to Insider Monkey’s hedge fund and institutional investor database, Chuck Royce’s Royce & Associates has the number one position in CIRCOR International, Inc. (NYSE:CIR), worth close to $73.8 million, corresponding to 0.4% of its total 13F portfolio. The second largest stake is held by GAMCO Investors, managed by Mario Gabelli, which holds a $63 million position; 0.4% of its 13F portfolio is allocated to the stock. Remaining professional money managers that hold long positions contain Legg Mason Capital Management, Martin Whitman’s Third Avenue Management, and Renaissance Technologies.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.